Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05480306
Title Phase 2 Study of DKN-01 in Colorectal Cancer (DeFianCe)
Acronym DeFianCe
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Leap Therapeutics, Inc.
Age Groups: senior | adult
Covered Countries USA | DEU

Additional content available in CKB BOOST